10 September(4:15pm start)
24 September (4:15pm start)
8 October (4:15pm start)
22 October (4:15pm start)
5 November (4:15pm start)
3 December (4:15pm start)
*All meetings are held in PK 214, and are open to the public. Please let the IRB Chair know if you plan to attend.
The SLU Institutional Review Board (IRB) reviews all research involving human subjects initiated by SLU faculty, staff, and students (regardless of the site where the research takes place) or any other research which is conducted on the SLU campus. This review process is completed to determine if a research project is in compliance with state and federal regulations regarding research involving human subjects. SLU also has a policy, which states: “Neither the members of the institutional review board nor the University are responsible for research performed without the approval of the Institutional Review Board. …If research is not reviewed by an IRB, the research has violated both the New York State Public Health Law, Article 24-A and the Code of Federal Regulations, Title 45, Part 46.
The role of the Institutional Review Board (IRB) is to assess the potential for risk to participants and to insure that they are fully informed about the research and risks so that they may voluntarily decide whether or not to participate. Both the Code of Federal Regulations (Title 45, Part 46) and New York State Public Health Law (Article 24-A) require all proposed research involving human participants be approved by the Institutional Review Board before it can proceed. Conducting research with human participants without prior IRB approval is not only a violation of St. Lawrence University policy, it is illegal. The guiding principles of the IRB in its review and decision process are taken from the Policy Statement of the St. Lawrence University Institutional Review Board:
In reviewing each proposal for projects involving human participants, the IRB shall determine whether these participants will be placed at risk and, if so, whether:
- The risks to the participant are so outweighed by the sum of the benefit to the participant or the importance of the knowledge to be gained as to warrant a decision to allow the participant to accept these risks;
- The rights and welfare of any such participants will be adequately protected; and
- Legally effective informed consent will be obtained by adequate and appropriate means.
- The person(s) proposed to conduct the project are competent and qualified.
Note that only faculty/staff of the University may serve as Principal Investigators (P.I.s) in research involving human participants. Students may not conduct such research without a faculty/staff P.I. who is the legally responsible party for the research.
The proposal process requires time and thoughtful attention. To help guide researchers through the proposal submission and review process, the following resources may be useful:
- Guidelines for Applying for Approval of Research Involving Human Participants
- Informed Consent Checklist
- Information for Faculty/Staff Directing Student Research Involving Human Participants
- Proposal Checklist for Student Projects
- New York State Public Health Law (Article 24-A)
NEW APPLICATIONS MUST BE SUBMITTED ELECTRONICALLY USING THE WEB FORM ACCESSED BY THE LINK BELOW. THIS IS THE ONLY ACCEPTABLE FORMAT FOR PROPOSAL SUBMISSIONS. Please note: The web form is not a working document. It is suitable only for submission of the completed proposal. Use a local document (e.g., Word) that you can save and edit to prepare for submission using the web form. You will NOT be able to save the web form to edit at a later date, so please do not use the form until your proposal is finalized.
- To submit a NEW APPLICATION for review of a proposal/protocol, use this web form for submission.
WHEN NOTIFYING THE IRB THAT YOUR RESEARCH INVOLVING HUMAN PARTICIPANTS HAS BEEN COMPLETED, OR IF YOU NEED TO REQUEST A CONTINUATION, USE THE LINK BELOW:
- To complete the form about STUDY COMPLETION or STUDY CONTINUATION, use this web form for submission.
If you have questions, please contact Dr. Karen Dillon O’Neil.